Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Buzz on the Bullboards: The 100-day checkup

This week, Canada witnessed a significant political shift as the Liberal Party made a Holyfield-esque comeback in the parliamentary elections, securing 168 seats. Although they fell short of the 172 seats needed for an outright majority, the victory marks a notable achiev...

Mobility and logistics under pressure: BYD, dynaCERT, and Daimler Truck put to the innovation test

The transport industry is at a crossroads: With CO2 limits getting stricter and supply chains needing to be smarter than ever, companies are struggling to find the right balance between efficiency and sustainability. According to the “NEW MOBILITY REPORT 2025,&CloseCurlyD...

Exosome production crucial for regenerative therapy research and development

NurExone Biologic Inc. (TSXV:NRX) has been making significant strides in the field of exosome-based therapies. And just last month the company announced the acquisition of a US master cell bank, followed by the formation of Exo-Top Inc. Lyndsay Malchuk from Stockho...

Three business reasons companies need to recycle e-waste

Author: Lane Simond . The most common narrative about recycling electronics is that it is better for the environment, but business owners have even more reasons to make sure their outdated technology gets into the hands of a reputable recycler. Three reasons to...

Lithium and copper demand set to grow in 2025

Lithium has already seen a rise in price since the U.S. presidential election and analysts predict a huge demand for copper . Grid Battery Metals (TSXV:CELL) has lithium projects in Nevada and a Copper in British Columbia and the company’s CEO, Tim Fer...

Meeting the projected lithium and copper supply imbalance

The following is a transcription of the above video, and The Market Online has edited it for clarity . Grid Battery Metals (TSX:CELL) has built a diverse portfolio of battery metal exploration targets, including three lithium properties in Nevada. Grid also has a c...

Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs

The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector. The S&P 500 and NASDAQ have hit fresh highs, a clear sign of a hungry market bolstered by technology stocks. This momentum has put a spot...

Minnesota helium project well positioned to help alleviate global shortage

By Marc Farrington In February this year, Pulsar Helium Inc (Pulsar) ( TSXV:PLSR ) announced extraordinarily high helium concentrations of up to 13.8% from its Jetstream No. 1 appraisal well drilled at its Topaz project in Minnesota. This has positioned Topaz as th...

Exploration company provides project portfolio update

The following is a transcription of the above video, and The Market Online has edited it for clarity . Banyan Gold Corp. (TSXV:BYN) is focused on exploration and advancing and de-risking its 7-million-ounce AurMac Gold Project in the Yukon, Canada&CloseCurlyQ...

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
1 2 3 4 5 6 7 8 9 10 ...